A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...
University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...
Thousands of men with prostate cancer will be offered a life-extending drug on the NHS within weeks. For the first time patients whose prostate cancer has not spread will be able to receive the drug ...
Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...
Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...
News-Medical.Net on MSN
PSA-based tool improves decision making for prostate cancer screening and treatment
In a previous study, the researchers showed that PSA scores can impact both doctor and patient behavior, leading to biopsy ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
The U.S. Food and Drug Administration (FDA) has granted fast track designation to Alessa Therapeutics for its lead product ...
Men with high‑risk locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, ...
A new way to prevent excruciating pain from the side effects of advanced prostate cancer therapy has been developed.Many men ...
NEW YORK (Reuters Health) - Men diagnosed with localized prostate cancer are more likely to be treated with proton beam therapy, a novel form of radiation therapy, if the technology is available ...
Though the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback